Evidence map›Paper›PMID 29611038›Full record

ArticleImmunologic research2018

Tumor necrosis factor gene polymorphisms are associated with systemic lupus erythematosus susceptibility or lupus nephritis in Mexican patients.

Julian Ramírez-Bello, Daniel Cadena-Sandoval, Jorge Flavio Mendoza-Rincón, Rosa Elda Barbosa-Cobos, Fausto Sánchez-Muñoz, Luis M Amezcua-Guerra, Mónica Sierra-Martínez, Silvia Jiménez-Morales

Abstract read
PubMed Publisher
In one paragraph

Article in Immunologic research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Association between tumor necrosis factor polymorphisms and rheumatoid arthritis as well as systemic lupus erythematosus: a meta-analysis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2019
    Pooled it
  3. Association ofJournal of clinical medicine · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Julian Ramírez-BelloUnidad de Investigación en Investigación en Enfermedades Metabólicas y Endócrinas, Hospital Juárez de México, Mexico City, Mexico. dr.julian.ramirez.hjm@gmail.com.ORCID http://orcid.org/0000-0002-4153-9315
Daniel Cadena-SandovalUnidad de Investigación en Investigación en Enfermedades Metabólicas y Endócrinas, Hospital Juárez de México, Mexico City, Mexico.
Jorge Flavio Mendoza-RincónLaboratorio de Oncología Molecular, Unidad de Diferenciacón Celular y Cáncer, FES-Zaragoza, UNAM, Mexico City, Mexico.
Rosa Elda Barbosa-CobosServicio de Reumatología, Hospital Juárez de México, Mexico City, Mexico.
Fausto Sánchez-MuñozDepartamento de Inmunología, Instituto Nacional de Cardiología, Mexico City, Mexico.
Luis M Amezcua-GuerraDepartamento de Inmunología, Instituto Nacional de Cardiología, Mexico City, Mexico.
Mónica Sierra-MartínezLaboratorio de Diagnóstico Molecular y Genética, Hospital Juárez de México, Mexico City, Mexico.
Silvia Jiménez-MoralesLaboratorio de Genómica del Cáncer, Instituto Nacional de Medicina Genómica, Mexico City, Mexico.
Hospital Juárez de México · MXInstituto Nacional de Cardiología · MXNational Institute of Genomic Medicine · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The TNF -238G/A (rs361525) and -308G/A (rs1800629) polymorphisms have consistently been associated with systemic lupus erythematosus (SLE) in several populations; however, these findings have not been verified in all populations. Here, we aimed to examine whether the TNF -238G/A, -308G/A, -376G/A (rs1800750), and -1031T/C (rs1799964) polymorphisms confer SLE or lupus nephritis (LN) susceptibility in a Mexican population. Our study included 442 patients with SLE and 495 controls. For genotyping, we used the TaqMan 5' allele discrimination assay. The TNF -238G/A and -1031T/C polymorphisms were associated with SLE susceptibility (odds ratio (OR) 2.1, p = 0.0005 and OR 1.4, p = 0.003, respectively). Gender stratification showed a strong association between TNF -238G/A and SLE in women (OR 2.2, p = 0.00006), while TNF -1031T/C had an OR of 1.5 (p = 0.007). With regard to the TNF -376G/A polymorphism, this also showed association with SLE susceptibility (OR 1.95, p = 0.036) and LN (OR 3.5, p = 0.01). In conclusion, our study provides the first demonstration of association between the TNF -376G/A polymorphism and SLE and LN susceptibility. In addition, our study is the second documenting an association of TNF -1031T/C with SLE susceptibility. We also observed a strong association between TNF -238G/A and SLE susceptibility. The TNF 308G/A polymorphism was not associated with SLE or LN.

Indexed as

Polymorphism, Single NucleotideAdultAllelesFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHaplotypesHumansLupus Erythematosus, SystemicLupus NephritisMaleMexicoMiddle AgedTumor Necrosis Factor-alphaTNF protein, humanTumor Necrosis Factor-alphaRheumatoid arthritisSusceptibilitySystemic lupus erythematosusTumor necrosis factor

Identifiers

PMID29611038
OpenAlexW2796115248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.